Kineticos is excited to partner with a few of the pioneers in cell therapy to bring you: Beyond CAR-T: Other Engineered Immune Cells. Our panelists come from Inceptor Bio, a novel Cell and Gene Therapy company. Mike Nicholson, CSO at Inceptor Bio, Chris Heery, CMO at Arcellx and SAB member at Inceptor Bio, and Mark Gilbert, Formerly of Juno Therapeutics and SAB member at Inceptor Bio discuss CAR-T for solid tumors, allogeneic CAR-T, CAR-NK and CAR-Macrophage, as well as manufacturing cell therapies.